HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koichi Taira Selected Research

Proton Pump Inhibitors

6/2023Responses of Proton Pump Inhibitors and Potassium-Competitive Acid Blockers According to Outcomes of Symptom, Endoscopy, and Histology in Patients With Eosinophilic Esophagitis.
1/2021Vonoprazan shows efficacy similar to that of proton pump inhibitors with respect to symptomatic, endoscopic, and histological responses in patients with eosinophilic esophagitis.
1/2020Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koichi Taira Research Topics

Disease

10Ulcerative Colitis
06/2022 - 01/2017
6Hemorrhage
01/2023 - 11/2017
6Inflammation (Inflammations)
08/2022 - 01/2020
6Ulcer
06/2022 - 10/2005
5COVID-19
10/2023 - 06/2021
5Eosinophilic Esophagitis
06/2023 - 12/2020
5Crohn Disease (Crohn's Disease)
06/2023 - 01/2017
5Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 09/2011
5Infections
02/2022 - 10/2007
5Stomach Neoplasms (Stomach Cancer)
04/2021 - 09/2012
4Neoplasm Metastasis (Metastasis)
04/2021 - 09/2012
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2023 - 01/2022
3Pathologic Constriction (Stenosis)
01/2023 - 03/2018
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2022 - 01/2018
3Lung Neoplasms (Lung Cancer)
01/2022 - 07/2013
3Dysbiosis
12/2021 - 11/2019
3Neoplasms (Cancer)
12/2021 - 09/2011
3Diarrhea
01/2021 - 01/2018
2Fistula
01/2023 - 05/2020
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2022 - 01/2008
2Hypersensitivity (Allergy)
09/2022 - 03/2021
2Eosinophilic enteropathy
08/2022 - 01/2022
2Fatigue
06/2022 - 01/2018
2Esophageal Stenosis (Esophageal Stricture)
06/2022 - 03/2018
2Bone Resorption
12/2021 - 07/2015
2Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 09/2014
2Mucositis
01/2021 - 01/2008
2Peptic Esophagitis (Reflux Esophagitis)
01/2019 - 07/2017
2Anorexia
01/2018 - 01/2008
2Stomach Ulcer (Gastric Ulcer)
01/2008 - 10/2005
1Chronic Disease (Chronic Diseases)
09/2023
1Abscess
01/2023
1Laryngeal Edema
01/2023
1Pharyngeal Neoplasms
01/2023
1Microsatellite Instability
01/2023
1Aspiration Pneumonia
01/2023
1Febrile Neutropenia
12/2022
1Intestinal Perforation
09/2022
1Brain Neoplasms (Brain Tumor)
09/2022
1Stroke (Strokes)
09/2022
1Hepatolenticular Degeneration (Wilson's Disease)
06/2022
1Fibrosis (Cirrhosis)
06/2022
1Fever (Fevers)
06/2022
1Tuberculosis (Tuberculoses)
06/2022
1Pleurisy (Pleuritis)
06/2022
1Neoplasms, Cystic, Mucinous, and Serous
02/2022
1Spondylitis
02/2022

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
06/2023 - 07/2015
4Capsules (Microcapsules)IBA
12/2022 - 11/2017
4InflammasomesIBA
06/2022 - 01/2020
4Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 01/2008
4Tacrolimus (Prograf)FDA LinkGeneric
01/2021 - 09/2017
4Infliximab (Remicade)FDA Link
03/2018 - 01/2017
4Cisplatin (Platino)FDA LinkGeneric
01/2018 - 09/2012
3Proton Pump InhibitorsIBA
06/2023 - 01/2020
3CytokinesIBA
08/2022 - 03/2021
3Proteins (Proteins, Gene)FDA Link
08/2022 - 12/2021
3Messenger RNA (mRNA)IBA
08/2022 - 10/2005
3CollagenIBA
06/2022 - 07/2013
3Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 03/2013
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2021 - 11/2019
2VaccinesIBA
10/2023 - 12/2021
2SteroidsIBA
09/2023 - 06/2022
2Adrenal Cortex Hormones (Corticosteroids)IBA
06/2023 - 04/2021
2AcidsIBA
06/2023 - 07/2017
2Bevacizumab (Avastin)FDA Link
09/2022 - 01/2019
2C-Reactive ProteinIBA
02/2022 - 01/2018
2NivolumabIBA
04/2021 - 01/2020
2Caspase 1 (ICE Protease)IBA
03/2021 - 01/2021
2Dinoprostone (PGE2)FDA Link
03/2021 - 01/2020
21- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
02/2021 - 01/2021
2MicroRNAs (MicroRNA)IBA
12/2020 - 07/2017
2Interleukin-6 (Interleukin 6)IBA
01/2019 - 01/2018
2CreatinineIBA
01/2018 - 07/2013
2Collagen Type I (Type I Collagen)IBA
07/2015 - 07/2013
1PotassiumIBA
06/2023
1Ustekinumab (CNTO 1275)FDA Link
06/2023
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
06/2023
1folfirinoxIBA
12/2022
1Corticotropin-Releasing HormoneIBA
08/2022
1CopperIBA
06/2022
1NucleotidesIBA
06/2022
1Acetic Acid (Vinegar)FDA LinkGeneric
06/2022
1Therapeutic UsesIBA
06/2022
1golimumabFDA Link
06/2022
1AntibodiesIBA
06/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022
1pirfenidoneIBA
06/2022
1Interferon-gamma (Interferon, gamma)IBA
06/2022
1AlbuminsIBA
02/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
02/2022

Therapy/Procedure

17Therapeutics
09/2023 - 01/2008
7Drug Therapy (Chemotherapy)
12/2021 - 01/2008
4Radiotherapy
01/2023 - 01/2008
2Chemoradiotherapy
01/2021 - 01/2008
2Adjuvant Chemotherapy
01/2018 - 03/2014
1Tracheotomy
01/2023
1Stents
12/2022
1Home Parenteral Nutrition
02/2022